Klaus P. Bøgesø - Concepedia

Author

Klaus P. Bøgesø

Also Known As

Bogeso, K.P., K. Bøgesø, K. P. BOGESO, K. P. Bøgeso, K. P. Bøgesø, K.P. Bogeso,, K.P. Bøgesø, Klaus BøGesø, Klaus P Bøgesø, Klaus P. Boegesoe

Publications

967

Citations

H-Index

Concepts

All Affiliations

Lundbeck (Denmark)University of Copenhagen Aarhus University Schools of Visual Arts, The Royal Danish Academy of Fine Arts Technical University of Denmark

About

Klaus P. Bøgesø is an author at Lundbeck (Denmark) specializing in medicine, pharmacology, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	374
2	Natural Sciences	5	5	179
3	Social Sciences	4	4	133
4	Engineering	2	2	33
5	Health Sciences	1	1	11

Klaus P. Bøgesø

Publications

766

Citations

H-Index

Page 1

	Year	Citations
3-Phenyl-1-indanamines. Potential antidepressant activity and potent inhibition of dopamine, norepinephrine, and serotonin uptake Klaus P. Bøgesø, A. V. Christensen, John Hyttel, Journal of Medicinal Chemistry	1985	147
Molecular determinants for selective recognition of antidepressants in the human serotonin and norepinephrine transporters Jacob Andersen, Nicolai Stuhr‐Hansen, Linda G. Zachariassen, Proceedings of the National Academy of Sciences Inhibitor SelectivityPsychotropic MedicationNeurotransmitterPsychopharmacologyCentral Binding Site	2011	79
Resolution, Absolute Stereochemistry, and Pharmacology of the S-(+)- and R-(-)-Isomers of the Apparent Partial AMPA Receptor Agonist (R,S)-2-Amino-3-(3-hydroxy-5-phenylisoxazol-4-yl)propionic Acid [(R,S)-APPA] Bjarke Ebert, Sibylle M. Lenz, Lotte Brehm, Journal of Medicinal Chemistry	1994	56
Heteroaryl Analogues of AMPA. Synthesis and Quantitative Structure−Activity Relationships Benny Bang‐Andersen, Sibylle M. Lenz, Niels Skjærbæk, Journal of Medicinal Chemistry	1997	50
Development of a Receptor-Interaction Model for Serotonin 5-HT2 Receptor Antagonists. Predicting Selectivity with Respect to Dopamine D2 Receptors Kim Andersen, Tommy Liljefors, Klaus Gundertofte, Journal of Medicinal Chemistry Medicinal Chemistry5-Ht2 Receptor AntagonistsPsychiatryBiochemistryMolecular Mechanics	1994	44
Preliminary Studies on the Absorption, Distribution, Metabolism, and Excretion of THIP in Animal and Man using <sup>14</sup>C‐labelled Compound Birgit Schultz, T. Aaes‐Jørgensen, Klaus P. Bøgesø, Acta Pharmacologica et Toxicologica Total DoseRadioactive ContaminationGas ChromatographyToxicologyToxicological Aspect	1981	43
Homology Modeling of the Serotonin Transporter: Insights into the Primary Escitalopram‐binding Site Anne Marie Jørgensen, Lena Tagmose, Anne Marie Jørgensen, ChemMedChem NeurotransmitterMolecular BiologyHomology ModelingNeurotransmissionMolecular Pharmacology	2007	42
Enhanced D1 Affinity in a Series of Piperazine Ring Substituted 1-Piperazino-3-Arylindans with Potential Atypical Antipsychotic Activity Klaus P. Bøgesø, Kristen Frederiksen, H O Hansen, Journal of Medicinal Chemistry PsychopharmacologyPharmacotherapyHeterocycle ChemistryPharmaceutical ChemistryEnhanced D1 Affinity	1995	42
Antihypertensive activity in a series of 1-piperazino-3-phenylindans with potent 5-HT2-antagonistic activity Klaus P. Bøgesø, Joern Arnt, V. Boeck, Journal of Medicinal Chemistry	1988	39
Molecular Dynamics Simulations of Na<sup>+</sup>/Cl<sup>−</sup>‐Dependent Neurotransmitter Transporters in a Membrane‐Aqueous System Anne Marie Jørgensen, Lena Tagmose, Anne Marie Jørgensen, ChemMedChem Proteinlipid InteractionProtein AssemblyNeurotransmitterMolecular BiologyMembrane‐aqueous System	2007	38

Page 1